Itaconix Share Discussion Threads

[lefrene] 07/3/2024 13:47

Newbies are lucky, they will arrive just as this 'gem' finally begins to walk the talk. I feel for those who have held through thick and thin of the past decade, but now it appears on the brink of finally becoming a very substantial business over the next 5 to 10 years.

The Share Soc video reveals just how many opportunities are now available to ITX, and that they have had the foresight to plan for this.

Good to see Mr Shaw making a better fist of it than in his previous live recordings. Plainly has sensibly been taking lessons in presentation, still no expert, but the improvement is most welcome.

[geraldus] 07/3/2024 13:39

Looks like the Budget is pro ISA investment for 'promising businesses'.Hopefully create some interest if probably only for a short timeframe.Must be a new generation of newbies out there. - Tee hee.

[lefrene] 07/3/2024 10:34

That Share Soc video reveals so much more than the rns. This is now imo a very sound investment, and I'm even more of the opinion that a predator will try to get them. The longer a predator waits, the more they will have to pay! :¬)

[gurunostradamus] 06/3/2024 16:44

Nice and steady as she goes…



free stock charts from uk.advfn.com

[lefrene] 06/3/2024 09:22

I guess one has to decide what a company in a rapidly expanding 'green' sector is actually worth? One with circa 350 patents, many products (100's?) on the shelves, sticky clients, plus new products coming along that have even bigger addressable markets. Also a company that has had the foresight to build in easily expandable production volume. Big Pharma must surely have them on the shopping list, particularly so when their beancounters will know that it's at breakeven with a slab of cash in the bank.

Current market cap £25 million, way too cheap in my view, to what it would be worth to a big outfit that's looking for a 'green' offering in their range. I'd want at least $100 million (£80 m). Thus if brokers are saying 600p, their view seems similar to mine. "Free Green" quite a good tag, big pharma can offer their consumers a halo at no extra cost, although of course they won't. Halo's don't come for free, they're worth a premium! :¬)

[wololol] 06/3/2024 06:52

I'm holding for the broker target at 600 within the next 6 months. That seems reasonable value to where the company is right now. Obviously subject to increased as they keep delivering and adding new revenue streams.

[dexdringle] 05/3/2024 19:07

Trouble is the £8.30 was a fantasy based on hype and a crazy market with free money buying, for silly money, anything even vaguely promising.

Now we have the reality of tight money and some sense returning.....

[lefrene] 05/3/2024 16:03

One hopes it has much much further to go. I hope the long term holders don't sell out at this stage. It's taken forever to get to the point of viability, and finally it looks like it's at breakeven with very good growth prospects.

Perhaps whatever story drove it up to the equivalent of £8.30p, will re-emerge, but it would have to be a better offer now that it's an actual business, and not just a bunch of hermit 'whitecoats' in a lab.

[bigbigdave] 05/3/2024 15:37

Nice to see this recovering.

[wololol] 05/3/2024 13:22

The herd hasn't arrived yet Fils. Best to get in early sub 200.

[fillspectre] 05/3/2024 13:07

The share volumes for this share are trivial. Unbelievably small. I can't believe so few are interested. Fils

[geraldus] 05/3/2024 12:14

The link on this board is for the ShareSoc presentation.There is a different interview with Vox over on LSE .

[timbo003] 05/3/2024 11:51

Thanks Rivaldo

The most interesting insight I gleaned from the presentation (Q and As) was that the production capacity (and sales) could increase by around 2-3 X (about £15m sales) without any further capex and that it would only require about £1.5m capex to introduce another production line to double capacity again to around £30m. They have around £10m in the bank so there is plenty of scope to increase production (and sales) multiple times without having to tap shareholders for further funds 🙂

[rivaldo] 05/3/2024 11:33

Cheers timbo003. A nice summary of the presentation posted elsewhere from AJP08 which I hope he won't mind me posting:

"Totally, he definitely is coming across as very excited about where we are now and where we are heading.There is a plan !!!

A few points I gleamed from the interview.

Dishwasher market, Excellent performance and cost plus sustainability, new catch phrase “Free Green”

Europe a bigger market for dishwasher tablets than current North American market and making good progress

European major German manufacturer was top rated for its formulation, high profile award and winning contracts in the private label sector

Scale up, first time I have heard him mention production facility in Europe when revenues dictate, but cannot be far off if he is mentioning it?

Leather made with chemistry from ITX, 2 accounts started in this area, major interest in both USA and Europe.

Plant based paint, in particular artwork, has huge potential

Superabsorbents – we have one in place, but are refining this application, to target the hygiene product market.

These markets are huge compared to the dishwasher market which we are currently in"

[lefrene] 05/3/2024 11:29

My thanks also. Mr Shaw did a very good presentation there. Good to hear the focus is on getting into profit, that'll make the company more investable from a fund managers point of view. Profit and growth via a heap of 'green' patents.

[timbo003] 05/3/2024 00:27

Here's the recording from last week's ShareSoc meeting:

[timbo003] 29/2/2024 16:24

>>>>krp

I was there, it was a good meeting, plenty of time for Q&As - quite a few questions concerning the pricing of the itaconix ingredients to the manufacturers, also a question on current capacity limits and what it would cost to increase the capacity substantially. The event was recorded and we were assured that the recordings will be made available shortly, if they do not appear by the beginning of next week, I will write up some notes.

[lefrene] 29/2/2024 14:46

This company now ticks so many of the right boxes, that it seems silly cheap at the current price. Surely at least $50 million cap at the current stage? It could almost be taken over by leveraging it's own money in the bank!

[krp10] 29/2/2024 14:46

Any update from Yesterday?

[geraldus] 28/2/2024 20:13

Yes,definitely an interesting change of focus and appealing to the masses.Will be interesting to knowhow far they have progressed with the SAP and the timeframe.

[lefrene] 28/2/2024 14:51

Thank you smudge104. Good to hear Mr Shaw highlighting the business attributes of the products, rather than just the 'technicals'. "Free Green" an excellent phrase to catch more business.

One hopes there's more news to come before too long, from new products for different markets.

[smudge104] 28/2/2024 14:46

From proactive investor today, targeting $100 million revs,

CEO John Shaw takes Proactive's Stephen Gunnion through a trading update that shows record 2023 revenue of $7.9 million, marking a 41% increase from the previous year.

Shaw attributed this success to the company's advancements in the detergent market across North America and Europe, emphasizing cost and performance benefits alongside sustainability. A significant growth of over 89% in European sales, reaching $1 million for the first time, highlighted the potential in the European market, particularly in dish detergents, where Itaconix's low-cost formulations are gaining traction among major retailers and private label brands.

Shaw also noted the company's development in offering plant-based polymers without imposing additional costs on consumers, a strategy dubbed "free green," which promotes sustainability without financial burdens.

The revenue growth stems from a balanced mix of new customer acquisitions and increased recurring revenue from the existing customer base. With a focus on expanding its product portfolio, Shaw mentioned ongoing developments in leather chemicals, paint, and plant-based superabsorbents, aiming to reach a $100 million revenue target in the future.

Looking ahead to 2024, Shaw expressed optimism, citing stabilized costs, minimal disruptions from shipping issues, and the introduction of new brands seeking Itaconix's reformulation expertise, promising continued growth from the momentum built in 2023.

[lefrene] 28/2/2024 09:58

rivaldo, I guess we need 'AI' in there to catch the eye lol.

I agree this should be on a growth valuation, rather than an industrial commodity valuation. But if they can keep growing at the current rate they will eventually get noticed, and get rated accordingly.

In the meantime they might get bought out. Getting ITX would put a predator in pole position in 'green' compliance, and burnish their 'green' credentials. I hang on to them for that possibility, in the meantime the value will rise as it finally becomes an actual real business. So now a low risk bet in the green segment.

Considering these hit £8.33 in old money on I presume bid rumours a couple of years ago when it still looked pretty dodgy, still begging for yet more money, then what would a bid have to be now? £15, £20?

It has circa $10 million in the bank, and judging by the amount of raw material being bought in, it's picking up momentum quickly. The risks have all but evapourated. I do hope this sort of stuff is being discussed by accountants in the likes of Unilever. :¬)